Taiwan Bio Therapeutics Co., Ltd Share Price

Equities

6892

TW0006892003

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 03:30:00 21/05/2024 am IST 5-day change 1st Jan Change
37.15 TWD +0.41% Intraday chart for Taiwan Bio Therapeutics Co., Ltd 0.00% +8.31%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Dynamic Chart
1 day+0.41%
Current month-1.20%
1 month+1.50%
3 months+8.78%
6 months+7.37%
Current year+8.31%
More quotes
1 week
36.60
Extreme 36.6
37.20
1 month
36.30
Extreme 36.3
38.65
Current year
32.60
Extreme 32.6
40.15
1 year
31.10
Extreme 31.1
40.15
3 years
26.35
Extreme 26.35
50.50
5 years
26.35
Extreme 26.35
50.50
10 years
26.35
Extreme 26.35
50.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15/18/15
Director of Finance/CFO - 01/21/01
Chief Operating Officer - 01/18/01
Members of the board TitleAgeSince
Director/Board Member 71 24/21/24
Director/Board Member - 16/15/16
Chairman - 16/17/16
More insiders
Taiwan Bio Therapeutics Co Ltd is a Taiwan-based company mainly engaged in the development of new allogeneic stem cell drugs and the provision of contract development and manufacturing organization (CDMO) services. The main products include Chondrochymal for the treatment of degenerative arthritis of the knee, Biochymal for the treatment of difficult non-healing wounds caused by lower extremity ischemia, OmniMSC/TBPCB201 for the treatment of acute myocardial infarction, and MSC-VEGF for the treatment of lower extremity ischemia. The cell processing center (CPC) is engaged in the provision of a full set of CDMO services, process scale-up services, inspection and development services, and quality control commissioned inspection services. The Company mainly operates in Taiwan market.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW